Patents by Inventor Ansu Kumar

Ansu Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Comprising Chloroquine, Metformin and Statin for Management of Cancer, Composition and Methods Thereof
    Publication number: 20220305000
    Abstract: The present disclosure relates to the field of oncology and particularly towards a combination therapy for treatment of cancer. In particular, the present disclosure provides a combination therapy comprising chloroquine, metformin and statin, for treatment/management of Myeloproliferative neoplasms (MPNs) or any associated condition. The combinations of the present disclosure show a synergistic cytotoxic activity against cancer cells. The present disclosure also relates to a composition comprising said combination, and a method for treatment/management of MPN or any associated condition by employing said composition or combination therapy. The present disclosure also provides combination of chloroquine, metformin and statin for use in treatment/management of MPN or any associated condition.
    Type: Application
    Filed: March 23, 2022
    Publication date: September 29, 2022
    Inventors: Ansu Kumar, Swati Khandelwal, Subrat Mohapatra, Himanshu Grover, Vivek Patil, Anuj Tyagi, Ashish Kumar Agrawal, Shweta Kapoor, Yatin Mundkur
  • Combination of nelfinavir, metformin and rosuvastatin for treating cancer caused by aberrations in PTEN/TP53
    Patent number: 10098880
    Abstract: The present disclosure relates to a method of treating cancer using a composition comprising Nelfinavir, Metformin, Rosuvastatin, optionally along with a pharmaceutically acceptable excipient. The said composition is used for the treatment of cancer caused due to aberration in PTEN gene, optionally along with aberration in TP53 gene and related genes selected from group comprising PI3K, CDKN2A, MDM2 and MDM4.
    Type: Grant
    Filed: May 5, 2015
    Date of Patent: October 16, 2018
    Assignee: CELL WORKS GROUP INC.
    Inventors: Shireen Vali, Shahabuddin Usmani, Zeba Sultana, Ansu Kumar, Taher Abbasi, Robinson Vidva
  • COMBINATION OF NELFINAVIR, METFORMIN AND ROSUVASTATIN FOR TREATING CANCER CAUSED BY ABERRATIONS IN PTEN/TP53
    Publication number: 20170056404
    Abstract: The present disclosure relates to a method of treating cancer using a composition comprising Nelfinavir, Metformin, Rosuvastatin, optionally along with a pharmaceutically acceptable excipient. The said composition is used for the treatment of cancer caused due to aberration in PTEN gene, optionally along with aberration in TP53 gene and related genes selected from group comprising PI3K, CDKN2A, MDM2 and MDM4.
    Type: Application
    Filed: May 5, 2015
    Publication date: March 2, 2017
    Inventors: Shireen Vali, Shahabuddin Usmani, Zeba Sultana, Ansu Kumar, Taher Abbasi, Robinson Vidva
  • COMPOSITION AND METHOD FOR TREATING CANCER
    Publication number: 20160058751
    Abstract: The present disclosure relates to a pharmaceutical composition and a kit to treat cancer. The disclosure provides a combination of compounds for use in the treatment of cancer. The disclosure further provides a process of preparing the composition and a method of treating a cancer associated with a RAS mutation or a RAS mutation along with any other mutation.
    Type: Application
    Filed: March 25, 2014
    Publication date: March 3, 2016
    Applicant: CELLWORKS GROUP, INC.
    Inventors: Shireen VALI, Shahabuddin Usmani, Zeba Sultanan, Shweta Kapoor, Ansu Kumar, Ashish Kumar Agrawal
  • SYSTEM AND METHOD FOR DEVELOPMENT OF THERAPEUTIC SOLUTIONS
    Publication number: 20150302167
    Abstract: The present disclosure relates to a system for obtaining a therapeutic solution for treatment of a disease or a disorder. The present disclosure also relates to a method of drug discovery and designing therapeutic solutions for various medical conditions, through the said system, comprising database, digital drug library and a processor.
    Type: Application
    Filed: November 8, 2013
    Publication date: October 22, 2015
    Applicant: CELLWORKS GROUP, INC.
    Inventors: Shireen Vali, Taher Abbasi, Pradeep Fernandes, Swaminathan Rajagopalan, Aftab Alam, Robinson Vidva, Prashant Ramachandran Nair, Shweta Kapoor, Saumya Radhakrishnan, Zeba Sultana, Kadambi Sarangapani Ramanujan, Krishna Kumar Tiwari, Ansu Kumar, Neeraj Kumar Singh, Ashish Kumar Agrawal, Anay Ashok Talawdekar, Shahabuddin Usmani, Ragini Singh